Quantcast

Johnson & Johnson Agrees to $22.9 Million Settlement for Drug Recall Lawsuits

J&J Agrees to Pay $22.9 Million in Drug Recall Lawsuit Alleging the Company Misled Investors Johnson & Johnson is the world’s largest maker of health care products, ranging from shampoo to hip replacement devices. In recent years, the company has faced a range of lawsuits, many involving personal injury from the company’s products. On … [Read more...]

Montana Settles Risperdal Lawsuit for $5.9 Million

Janssen To Pay $5.9 Million Settlement to Montana for Misleading Ads In March of this year, Montana State Attorney General Tim Fox announced that Johnson & Johnson’s subsidiary Janssen Pharmaceuticals agreed to pay $5.9 million to settle allegations in the state regarding its antipsychotic drug, Risperdal. Like many Risperdal settlements in … [Read more...]

Xarelto Under Drug Recall Due to Contamination

Janssen Issues Drug Recall for Xarelto After Discovering Contamination Johnson & Johnson’s pharmaceutical subsidiary Janssen issued a drug recall in mid-October for 13,500 bottles of their controversial blood thinner, Xarelto, after learning of a microbial infection in a sample. A drug recall notice in the most recent FDA Enforcement Report … [Read more...]

J&J May Pay Additional $250 Million to Settle DePuy ASR Claims

J&J May Offer $250 Million to Settle DePuy ASR Claims Not Covered in Original Settlement Johnson & Johnson may offer an additional settlement of $250 million to plaintiffs in a DePuy ASR multidistrict litigation (MDL) who were not covered by the original $2.5 billion settlement, which was finalized in November of last year. The … [Read more...]

New Documents in DePuy ASR Lawsuit Reveal J&J Knew About Device Failure Rates

Court Documents for First DePuy ASR Lawsuit Reveal Manufacturer Intentionally Released Defective Device Loren Kransky’s DePuy ASR personal injury lawsuit has gone to trial, and court documents released on Friday, January 25th reveal that Johnson & Johnson knew about the all-metal hip replacements’ design flaws and high failure rates, but chose … [Read more...]

Risperdal Personal Injury Lawsuits Growing in Number

Johnson & Johnson Faces Numerous, Serious Personal Injury Lawsuits Due to Taking Risperdal In September, Johnson & Johnson issued a recall notice for Risperdal Consta, a long-acting form of the anti-psychotic drug, Risperdal. At the time, the pharmaceutical manufacturer believed that there were no injuries as a result of taking the … [Read more...]

UK launches investigation into DePuy hip replacement devices

The Medicines and Healthcare products Regulatory Agency in the United Kingdom is investigating the safety of all-metal hip replacement devices like DePuy ASR. Reportedly, metal-on-metal devices have caused serious complications within a few years after surgery, including tissue degeneration, infection, joint stiffening and pain, and … [Read more...]

Plaintiffs in First DePuy Hip Replacement Settlement File to Strike Confidentiality

The first three plaintiffs fighting against faulty hip replacement devices manufactured by Johnson & Johnson’s DePuy division supposedly settled last week for a lower amount than expected. Now, however, the plaintiffs are filing for a “Motion Striking Confidentiality from Settlement Agreement,” alleging that the defendants released information … [Read more...]

J&J Accused of Ignoring DePuy Pinnacle All-Metal Hip Implant Failures

Jury Hears Arguments Against J&J and DePuy for Ignoring All-Metal Hip Implant Failures for Profit As the 7-week personal injury trial of plaintiff Kathleen Herlihy-Paoli against DePuy’s all-metal Pinnacle hip implant continues, the jury heard accusations that Johnson & Johnson, the parent company of subsidiary DePuy Orthopedics, ignored … [Read more...]

Next DePuy All-Metal Hip Replacement Lawsuit Scheduled

Federal Judge Schedules DePuy ASR All-Metal Hip Replacement Lawsuit After 2-week Delay The first federal-level trial against Johnson & Johnson’s DePuy ASR all-metal hip replacement device has finally been scheduled, after a two week delay. US District Judge David Katz scheduled the case to begin on Monday, September 23rd. The DePuy personal … [Read more...]

BestLawyers.comAVBetter Business Bureau